Disease control and safety of belimumab plus standard therapy over 7 years in patients with systemic lupus erythematosus.
Disease control and safety of belimumab plus standard therapy over 7 years in patients with systemic lupus erythematosus. J Rheumatol. 2014 Feb; 41(2):300-9.